In present study, we investigated the function of VCP in MM to confirm if VCP was representing a potential therapeutic target, and identified that a specific VCP inhibitor (VCP20) targeted VCP to inhibit MM cell proliferation and osteoclast differentiation. This evidence concerns the gene VCP and Miyoshi myopathy.